Literature DB >> 18332480

SOCS3 in liver regeneration and hepatocarcinoma.

Joanne Elliott1.   

Abstract

Cytokine responses are stringently controlled by a family of proteinsSTAT3 termed the suppressors of cytokine signaling (SOCS), and deregulation of SOCS function is associated with many diseases, including several cancers, disorders in hematopoiesis, and autoimmune diseases. Our current understanding of the divergent roles of SOCS3 has recently improved and indicates that SOCS3 is critical in modulating cytokine-mediated and neoplastic-proliferative responses in the liver. The generation of hepatocyte-specific Socs3 knockout mice suggests that loss of SOCS3 expression encourages hepatocyte proliferation, survival, and hepatocellular carcinoma formation. By elucidating the regulation of pathways leading to liver regeneration we may gain useful insights to control liver disease and tumor growth.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18332480     DOI: 10.1124/mi.8.1.5

Source DB:  PubMed          Journal:  Mol Interv        ISSN: 1534-0384


  5 in total

1.  Interference of suppressor of cytokine signaling 3 promotes epithelial-mesenchymal transition in MHCC97H cells.

Authors:  Yuan-Yuan Ji; Zhi-Dong Wang; Zong-Fang Li; Ke Li
Journal:  World J Gastroenterol       Date:  2013-02-14       Impact factor: 5.742

2.  In vitro and in vivo conditional sensitization of hepatocellular carcinoma cells to TNF-induced apoptosis by taxol.

Authors:  V G Minero; D De Stefanis; P Costelli; F M Baccino; G Bonelli
Journal:  Cell Cycle       Date:  2015       Impact factor: 4.534

3.  Context-Specific Growth Hormone Signaling through the Transcription Factor STAT5: Implications for the Etiology of Hepatosteatosis and Hepatocellular Carcinoma.

Authors:  Kyung Hyun Yoo; Myunggi Baik; Lothar Hennighausen
Journal:  Genes Cancer       Date:  2011-01

4.  Dimethyl fumarate suppresses hepatocellular carcinoma progression via activating SOCS3/JAK1/STAT3 signaling pathway.

Authors:  Hua Liu; Xiao-De Feng; Beng Yang; Rong-Liang Tong; Yue-Jie Lu; Di-Yu Chen; Lin Zhou; Hai-Yang Xie; Shu-Sen Zheng; Jian Wu
Journal:  Am J Transl Res       Date:  2019-08-15       Impact factor: 4.060

5.  Interleukin-6 inhibition of peroxisome proliferator-activated receptor alpha expression is mediated by JAK2- and PI3K-induced STAT1/3 in HepG2 hepatocyte cells.

Authors:  Guat-Siew Chew; Stephen Myers; Alexander Chong Shu-Chien; Tengku Sifzizul Tengku Muhammad
Journal:  Mol Cell Biochem       Date:  2013-11-16       Impact factor: 3.396

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.